41% of LGBTQ youth seriously considered suicide last year, according to the nati...
Japanese drugmaker Astellas said it would acquire eye drug developer Iveric Bio ...
“I’ve admired the fact that Sam has brought to the market seven separate drugs. ...
Academic and medical communities in the United States seem uninterested in the h...
You've probably heard of Ozempic and even Mounjaro. But a clutch of startups say...
Geisinger’s stumbles opened a door for Kaiser Permanente. What does that say abo...
Bright is looking to sell off the Medicare Advantage plans it manages in Califor...
Once bullish on digital health, the pharmaceutical company Orexo has hit a wall ...
At an event highlighting past STAT Wunderkinds, one researcher spoke to the impo...
In a survey of patient advocacy groups, 52% thought brand-name pharma companies ...
More than half of patient groups surveyed in a new report say pharma isn't doing...
A bill against supervised drug use sites suggests U.S. attitudes toward harm red...
Surprising research suggests radiation may reprogram misfiring heart cells to co...
“I'm not hopeful because lockdowns seem like our new normal,” said one prisoner ...
In one study, researchers were able to avoid leg amputation in 75% of chronic li...
Researchers have developed a new plan to prevent more cases of preeclampsia, a l...
